Action Changement Date
AbbVie USD 5.31B 178M 2026-09
Abbott USD 7.34B 22M 2026-09
ALKERMES USD 261.1M 37.86M 2026-09
Amgen USD 6.39B 169M 2026-09
AstraZeneca USD 6.93B 362M 2026-06
Bayer EUR 11.97B 43M 2026-06
Biogen USD 2.22B 159.9M 2026-09
Bristol-Myers Squibb USD 2.7B 33M 2026-09
Coherus Biosciences USD 5.67M 842K 2026-06
Drreddys Laboratories INR 81.18B 4.65B 2026-09
Eli Lilly USD 18.19B 1.4B 2026-09
Gilead Sciences USD 1.9B 57M 2026-09
GlaxoSmithKline GBP 6.28B 125M 2026-06
Glaxosmithkline GBP 6.3B 143M 2026-09
J&J USD 15.38B 233M 2026-09
Medtronic USD 6.22B 264M 2026-06
Merck USD 6.16B 43M 2026-09
Neurocrine Biosciences USD 66.1M 38.1M 2026-09
Novartis USD 6.1B 116M 2026-09
Novartis USD 6.1B 182M 2026-09
Pacira USD 3.83B 3.69B 2026-09
Perrigo USD 1.01B 50.7M 2026-09
Pfizer USD 10.02B 77M 2026-09
Phibro Animal Health USD 567.14M 32.26M 2026-09
Prestige Brands USD 179.2M 11.01M 2026-09
Regeneron Pharmaceuticals USD 2.89B 189.7M 2026-09
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 24.12B 620M 2026-06
Sanofi EUR 24.12B 620M 2026-06
Vertex Pharmaceuticals USD 2.25B 480.2M 2026-09
Zoetis USD 2.54B 38M 2026-09